These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38116046)

  • 1. Summary of the National Advisory Committee on Immunization (NACI) Seasonal Influenza Vaccine Statement for 2022-2023.
    Sinilaite A; Papenburg J
    Can Commun Dis Rep; 2022 Sep; 48(9):373-382. PubMed ID: 38116046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Summary of the National Advisory Committee on Immunization (NACI) Seasonal Influenza Vaccine Statement for 2021-2022.
    Can Commun Dis Rep; 2021 Sep; 47(9):372-380. PubMed ID: 34650334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Summary of the National Advisory Committee on Immunization (NACI) Seasonal Influenza Vaccine Statement for 2023-2024.
    Sinilaite A; Siu W; Papenburg J
    Can Commun Dis Rep; 2023 Oct; 49(10):406-412. PubMed ID: 38476927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Summary of the National Advisory Committee on Immunization (NACI) Statement on Seasonal Influenza Vaccine for 2016-2017.
    Gemmill I; Zhao L; Cochrane L;
    Can Commun Dis Rep; 2016 Sep; 42(9):188-192. PubMed ID: 29770030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Summary of the NACI Seasonal Influenza Vaccine Statement for 2019-2020.
    Zhao L; Young K; Gemmill I
    Can Commun Dis Rep; 2019 Jun; 45(6):149-155. PubMed ID: 31285706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Summary of the NACI Seasonal Influenza Vaccine Statement for 2018-2019.
    Vaudry W; Zhao L; Stirling R
    Can Commun Dis Rep; 2018 Jun; 44(6):123-128. PubMed ID: 31015804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Summary of the National Advisory Committee on Immunization (NACI) Statement on Seasonal Influenza Vaccine for 2015-2016.
    Gemmill I;
    Can Commun Dis Rep; 2015 Oct; 41(10):227-232. PubMed ID: 29769917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Summary of the NACI Seasonal Influenza Vaccine Statement for 2020-2021.
    Young K; Gemmill I; Harrison R
    Can Commun Dis Rep; 2020 May; 46(5):132-137. PubMed ID: 32558810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Summary of the NACI Statement on Seasonal Influenza Vaccine for 2017-2018.
    Vaudry W; Stirling R;
    Can Commun Dis Rep; 2017 May; 43(5):96-103. PubMed ID: 29770072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Summary of the NACI Supplemental Statement on Mammalian Cell Culture-Based Influenza Vaccines.
    Sinilaite A; Gemmill I; Harrison R
    Can Commun Dis Rep; 2020 Oct; 46(10):324-332. PubMed ID: 33316000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Summary of the National Advisory Committee on Immunization (NACI) Statement-Recommendation on Repeated Seasonal Influenza Vaccination.
    Sinilaite A; Young K; Papenburg J
    Can Commun Dis Rep; 2023 Apr; 49(4):99-102. PubMed ID: 38298903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Summary of the NACI Update on Herpes Zoster Vaccines.
    Warrington R; Ismail S;
    Can Commun Dis Rep; 2018 Sep; 44(9):220-225. PubMed ID: 31015813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2022-23 Influenza Season.
    Grohskopf LA; Blanton LH; Ferdinands JM; Chung JR; Broder KR; Talbot HK; Morgan RL; Fry AM
    MMWR Recomm Rep; 2022 Aug; 71(1):1-28. PubMed ID: 36006864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season.
    Grohskopf LA; Alyanak E; Ferdinands JM; Broder KR; Blanton LH; Talbot HK; Fry AM
    MMWR Recomm Rep; 2021 Aug; 70(5):1-28. PubMed ID: 34448800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Summary of the National Advisory Committee on Immunization (NACI) Supplemental Statement on Recombinant Influenza Vaccines.
    Gil A; Sinilaite A; Papenburg J
    Can Commun Dis Rep; 2022 Sep; 48(9):383-391. PubMed ID: 38116047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Summary of the NACI Statement on the Use of Bivalent Factor H Binding Protein Meningococcal Serogroup B (MenB-fHBP) Vaccine for the Prevention of Meningococcal B Disease.
    Harrison R; Stirling R; Baclic O; Vaudry W
    Can Commun Dis Rep; 2020 Feb; 46(2-3):36-39. PubMed ID: 32167082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Technical guidelines for seasonal influenza vaccination in China (2021-2022)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) , Influenza Vaccination TWG
    Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Oct; 42(10):1722-1749. PubMed ID: 34814607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Summary of the National Advisory Committee on Immunization (NACI) Updated Guidance on Influenza Vaccination During Pregnancy.
    Siu W; Sinilaite A; Papenburg J
    Can Commun Dis Rep; 2024 Apr; 50(3-4):86-92. PubMed ID: 38716409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Technical guidelines for seasonal influenza vaccination in China (2023-2024)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG), Influenza Vaccination TWG
    Zhonghua Liu Xing Bing Xue Za Zhi; 2023 Oct; 44(10):1507-1530. PubMed ID: 37875437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Summary of the National Advisory Committee on Immunization's updated recommendations on human papillomavirus (HPV) vaccines: Nine-valent human papillomavirus (HPV) of minimum intervals between doses in the HPV immunization schedule.
    Tunis MC; Deeks SL;
    Can Commun Dis Rep; 2016 Jul; 42(7):149-151. PubMed ID: 29770021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.